{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:49:50Z","timestamp":1792010990220,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.canep.2026.103253","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:56:21Z","timestamp":1791935781000},"page":"103253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The prevalence of cardiac dysfunction among breast cancer survivors: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"105","author":[{"given":"Laurine","family":"van der Wal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Tjepkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertje","family":"Liemburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Famke","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariken","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Blanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertruida","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Brandenbarg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.canep.2026.103253_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"15","key":"10.1016\/j.canep.2026.103253_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","article-title":"Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status","volume":"99","author":"Glass","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.canep.2026.103253_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx030","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132014, Featuring Survival","volume":"109","author":"Jemal","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.canep.2026.103253_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ejhf.1620","article-title":"Heart failure after treatment for breast cancer","volume":"22","author":"Boekel","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"15","key":"10.1016\/j.canep.2026.103253_bib7","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1200\/JCO.2004.03.098","article-title":"Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group","volume":"22","author":"Bonneterre","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.canep.2026.103253_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.canep.2026.103253_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur. Heart J. - Cardiovasc. Imaging"},{"issue":"12","key":"10.1016\/j.canep.2026.103253_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"Galderisi","year":"2017","journal-title":"Eur. Heart J. - Cardiovasc. Imaging"},{"issue":"36","key":"10.1016\/j.canep.2026.103253_bib11","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.canep.2026.103253_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.013","article-title":"Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study","volume":"81","author":"Boerman","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jmrs.89","article-title":"The cardiac dose-sparing benefits of deep inspiration breath-hold in left breast irradiation: a systematic review","volume":"62","author":"Smyth","year":"2015","journal-title":"J. Med. Radiat. Sci."},{"key":"10.1016\/j.canep.2026.103253_bib14","series-title":"Evidence Reviews for Breast Radiotherapy: Early and Locally Advanced Breast Cancer: Diagnosis and Management: Evidence Review H.","article-title":"NICE Evidence Reviews Collection","author":"National Guideline A","year":"2018"},{"key":"10.1016\/j.canep.2026.103253_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.canep.2026.103253_bib16","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2026.103253_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-015-3454-8","article-title":"Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer","volume":"152","author":"Caram","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.canep.2026.103253_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clbc.2025.03.018","article-title":"Early Breast Cancer Treatment and Cardiac Events: A Systematic Review","volume":"25","author":"Meillan","year":"2025","journal-title":"Clin. Breast Cancer"},{"issue":"7","key":"10.1016\/j.canep.2026.103253_bib19","first-page":"908","article-title":"Long-term Risk of Heart Failure and Myocardial Dysfunction After Thoracic Radiotherapy: A Systematic Review","volume":"32","author":"Nolan","year":"2016","journal-title":"Can. J. Cardiol."},{"issue":"8","key":"10.1016\/j.canep.2026.103253_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"35","author":"Armenian","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"41","key":"10.1016\/j.canep.2026.103253_bib21","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.canep.2026.103253_bib22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.canep.2026.103253_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer","year":"2016","journal-title":"J. Med. Libr. Assoc. JMLA"},{"key":"10.1016\/j.canep.2026.103253_bib24","unstructured":"Quality assessment tool for observational cohort and cross-sectional studies - NHLBI, NIH [cited 2024 10-12]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2022.01.020","article-title":"Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial","volume":"113","author":"Abraham","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.canep.2026.103253_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2015.61.8413","article-title":"Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial","volume":"34","author":"Advani","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2026.103253_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041278","article-title":"Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer","volume":"12","author":"Cronin","year":"2023","journal-title":"J. Clin. Med."},{"issue":"17","key":"10.1016\/j.canep.2026.103253_bib28","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.ejca.2015.08.011","article-title":"Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy","volume":"51","author":"de Azambuja","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"20","key":"10.1016\/j.canep.2026.103253_bib29","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2013.53.9288","article-title":"Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01)","volume":"32","author":"de Azambuja","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canep.2026.103253_bib30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2007.11.8877","article-title":"Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897","volume":"26","author":"Ganz","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2026.103253_bib31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0360-3016(94)90500-2","article-title":"Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy","volume":"28","author":"Gyenes","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.canep.2026.103253_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ejhf.1610","article-title":"Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50\u2009years","volume":"22","author":"Jacobse","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.canep.2026.103253_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286364","article-title":"Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients","volume":"18","author":"Kwan","year":"2023","journal-title":"PLoS. One"},{"issue":"20","key":"10.1016\/j.canep.2026.103253_bib34","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.jacc.2017.03.560","article-title":"Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients","volume":"69","author":"Maestrini","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.canep.2026.103253_bib35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-016-3781-4","article-title":"Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up","volume":"156","author":"Murtagh","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.canep.2026.103253_bib36","first-page":"511","article-title":"Late consequences of chemotherapy on left ventricular function in women with breast cancer","volume":"13","author":"Nabati","year":"2022","journal-title":"Casp. J. Intern. Med."},{"issue":"6","key":"10.1016\/j.canep.2026.103253_bib37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cncr.32653","article-title":"Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial","volume":"126","author":"Papakonstantinou","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(02)00133-0","article-title":"Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy","volume":"64","author":"Seddon","year":"2002","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.2001.19.1.37","article-title":"Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation","volume":"19","author":"Zambetti","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canep.2026.103253_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/heartjnl-2023-323437","article-title":"Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer","volume":"110","author":"Glen","year":"2024","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.canep.2026.103253_bib41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.1997.489","article-title":"Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer","volume":"76","author":"de Graaf","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2026.103253_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurjpc\/zwad348","article-title":"Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy","volume":"31","author":"Jacobs","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.canep.2026.103253_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ehjci\/jead338","article-title":"Cardiac structure, function, and coronary anatomy 10 years after isolated contemporary adjuvant radiotherapy in breast cancer patients with low cardiovascular baseline risk","volume":"25","author":"Krug","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.23.01779","article-title":"Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors","volume":"43","author":"Bostany","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2026.103253_bib45","first-page":"1","article-title":"Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls","volume":"11","author":"S\u00e6ter","year":"2025","journal-title":"Cardiooncology"},{"issue":"10","key":"10.1016\/j.canep.2026.103253_bib46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamacardio.2019.2952","article-title":"Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis","volume":"4","author":"Oikonomou","year":"2019","journal-title":"JAMA Cardiol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782126002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:24:13Z","timestamp":1792009453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782126002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S1877782126002699"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.103253","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of cardiac dysfunction among breast cancer survivors: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.103253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103253"}}